Matthew Wood

Matthew Wood

Company: Luxturna Patient (UK)


Panel Discussion: Ophthalmic Gene Therapy Patient Perspective 4:05 pm

Do patients feel they know what treatments are available to them? Is there trial data available to patients so they can decide if they want to participate? How can an open line of communication be developed between patients and the industry?Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.